SC 13G/A | 2020-02-14 | ORBIMED CAPITAL LLC | Foamix Pharmaceuticals Ltd. | 2,577,982 | 4.2% | EDGAR |
SC 13G/A | 2020-02-14 | GREAT POINT PARTNERS LLC | Foamix Pharmaceuticals Ltd. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | Foamix Pharmaceuticals Ltd. | 11,203,881 | 18.3% | EDGAR |
SC 13G/A | 2020-01-14 | Delaware Street Capital Master Fund, L.P. | Foamix Pharmaceuticals Ltd. | 3,365,000 | 5.5% | EDGAR |
SC 13G | 2019-08-15 | Delaware Street Capital Master Fund, L.P. | Foamix Pharmaceuticals Ltd. | 3,062,593 | 5.0% | EDGAR |
SC 13G/A | 2019-08-06 | PERCEPTIVE ADVISORS LLC | Foamix Pharmaceuticals Ltd. | 11,203,881 | 18.4% | EDGAR |
SC 13G/A | 2019-02-14 | GREAT POINT PARTNERS LLC | Foamix Pharmaceuticals Ltd. | 4,047,561 | 7.5% | EDGAR |
SC 13G/A | 2019-02-14 | PERCEPTIVE ADVISORS LLC | Foamix Pharmaceuticals Ltd. | 4,661,824 | 8.6% | EDGAR |
SC 13G/A | 2019-02-13 | BAKER BROS. ADVISORS LP | Foamix Pharmaceuticals Ltd. | 498,189 | 0.9% | EDGAR |
SC 13G | 2019-02-13 | ORBIMED CAPITAL LLC | Foamix Pharmaceuticals Ltd. | 5,195,330 | 9.6% | EDGAR |
SC 13G/A | 2018-10-10 | GREAT POINT PARTNERS LLC | Foamix Pharmaceuticals Ltd. | 4,030,268 | 7.4% | EDGAR |
SC 13G | 2018-09-24 | PERCEPTIVE ADVISORS LLC | Foamix Pharmaceuticals Ltd. | 3,307,424 | 6.3% | EDGAR |
SC 13G/A | 2018-02-14 | GREAT POINT PARTNERS LLC | Foamix Pharmaceuticals Ltd. | 4,781,708 | 12.9% | EDGAR |
SC 13G | 2018-02-13 | Tamarkin Dov | Foamix Pharmaceuticals Ltd. | 2 | 7.0% | EDGAR |
SC 13G | 2018-02-13 | Eini Meir | Foamix Pharmaceuticals Ltd. | 3,015,024 | 8.0% | EDGAR |
SC 13G/A | 2017-05-10 | GREAT POINT PARTNERS LLC | Foamix Pharmaceuticals Ltd. | 4,781,708 | 12.9% | EDGAR |
SC 13G/A | 2017-02-21 | Eini Meir | Foamix Pharmaceuticals Ltd. | 3,065,641 | 8.0% | EDGAR |
SC 13G/A | 2017-02-21 | Tamarkin Dov | Foamix Pharmaceuticals Ltd. | 2,930 | 7.6% | EDGAR |
SC 13G/A | 2017-02-14 | GREAT POINT PARTNERS LLC | Foamix Pharmaceuticals Ltd. | 3,000,000 | 8.2% | EDGAR |
SC 13G/A | 2017-02-14 | BAKER BROS. ADVISORS LP | Foamix Pharmaceuticals Ltd. | 2,466,702 | 6.6% | EDGAR |